Purple Biotech Reports Temporary Medical Leave of CEO Gil Efron

Board of Directors appoints Isaac Israel, Board member and former CEO, as acting CEOCompany’s business plan and clinical development programs continue as planned REHOVOT, Israel, March 24, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (

Related Keywords

Israel ,Rehovot ,Hamerkaz ,Gil Efron ,Eric Rowinsky ,Harriet Ullman ,Lior Fhima ,Company Board Of Directors ,Bristol Myers Squibb ,Company Contact ,Product Communications ,Drug Administration ,Purple Biotech Ltd ,Exchange Commission ,Immunorizon Ltd ,Isaac Israel ,Purple Biotech ,Tumor Associated Antigen ,Looking Statements ,Safe Harbor Statement ,Private Securities Litigation Reform Act ,Annual Report ,Registration Statements ,Public Relations ,